U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07754474) titled 'A Study to Test How Well Different and Multiple Doses of BI 3034701 Are Tolerated in People Living With Overweight or Obesity' on Aug. 05.
Brief Summary: The main objectives of this trial are to investigate safety, tolerability of alternative dose titration strategies and pharmacokinetics (PK) of BI 3034701 in participants with overweight / obesity and at least one weight related co-morbidity following subcutaneous administration.
Study Start Date: Sept. 01
Study Type: INTERVENTIONAL
Condition:
Overweight
Obesity
Intervention:
DRUG: BI 3034701
BI 3034701
DRUG: Placebo
Placebo
Recruitment Status: NOT_YET_RECRUITING
Sponsor...